Fidelity Independent Adviser

Two trades place biotechnology prominently in two of Fidelity Independent Adviser’s model portfolios: Fidelity Select Portfolio and NTF Sector Portfolio.

Don Dion, publisher of Fidelity Independent Adviser’s ETF Momentum Tracker, announced that he would be selling the International Portfolio position, iShares Austria (EWO), and would be buying iShares Singapore (EWS) with the proceeds.

Don Dion, publisher of Fidelity Independent Adviser’s ETF Momentum Tracker, announced today that despite recent setbacks, iShares COMEX Gold (IAU) has risen more than 8% since he added it to the ETF Momentum Tracker portfolio in January.

Don Dion, publisher of Fidelity Independent Adviser, and president of Dion Money Management, announced that he would be shifting from Communications Equipment (FSDCX) to Medical Equipment (FSMEX) in the latest edition of Sector Momentum Tracker.

Banking ETFs have seen a bounce in price, but Don Dion doubts that they can gain momentum: Fidelity Independent Adviser’s PowerShares Momentum Tracker sees more downside for financial ETFs.

Fidelity Independent Adviser’s PowerShares Momentum Tracker takes an in depth look at PowerShares Global Wind Energy ETF (PWND) in its latest issue, released yesterday.

Publisher Don Dion notes that the “Mexican market is showing surprising strength, despite U.S. Downturn.”

In the latest issue of the 401(k) Accelerator, publisher Don Dion examines the possibilities available to investors who would like to invest their 401(k) overseas.

As mixed news rolls in for the world’s largest pharmaceutical companies, Fidelity Independent Adviser’s Sector Momentum Tracker announced Monday that Fidelity Select Pharmaceuticals (FPHAX) has made gains on the Sector Momentum Table.

As biotech begins this week with a jump start, Don Dion, publisher of ETF Momentum Tracker, announced that iShares Nasdaq Biotechnology (IBB) has moved up his Sector Momentum Table.